CURAMIR THERAPEUTICS
Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability. Its novel approach addresses current challenges associated with both chemoresistance in cancer and effective systemic delivery of miRNA mimics.
CURAMIR THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.curamirtherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
Delos Capital
Delos Capital investment in Series A - Curamir Therapeutics
Official Site Inspections
http://www.curamirtherapeutics.com
- Host name: 104.17.54.64
- IP address: 104.17.54.64
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Curamir Therapeutics"
Leadership – Curamir Therapeutics, Inc.
3-G Gill Street Woburn, MA 01801. 339-999-2556. © All rights reserved. Powered by getfused Home; Careers; Contact UsSee details»
Curamir Therapeutics - Crunchbase Company Profile & Funding
Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA …See details»
Jingfang Ju – Curamir Therapeutics, Inc.
Dr. Jingfang Ju is Professor at Renaissance School of Medicine, Stony Brook University and is co-founder of Curamir Therapeutics Inc. Dr. Ju is the inventor of the company’s miRNA-based cancer therapeutic platform technology and …See details»
Curamir Therapeutics, Inc. | LinkedIn
Curamir Therapeutics, Inc. | 101 followers on LinkedIn. Finding RNA-targeted cures for cancer. | Curamir strives to improve patients' lives by developing transformative RNA-targeted life …See details»
Curamir Therapeutics - Overview, News & Similar companies
View Curamir Therapeutics (www.curamirtherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Curamir Therapeutics - VentureRadar
"Curamir Therapeutics Inc. is a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics. Curamir is developing innovative therapeutics …See details»
Curamir Company Profile 2024: Valuation, Funding & Investors
Curamir General Information Description. Operator of a biotechnology company intended to offer miRNA (micro RNA) based cancer therapeutics. The company develops innovative …See details»
Curamir Therapeutics, Inc. - Company Profile & Staff Directory
Curamir strives to improve patients' lives by developing transformative RNA-targeted life-changing oncology therapies. We are building an RNA-targeted technology platform with broad …See details»
Delos Capital Announces the Launch of Curamir Therapeutics Inc.
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering …See details»
Curamir Therapeutics - Products, Competitors, Financials, …
Curamirtherapeutics.com. Overview & Products; Financials; Founded Year 2019. Stage Series A | Alive. Total Raised $10M. Last Raised $10M | 5 yrs ago. About Curamir Therapeutics. Curamir …See details»
Curamir Therapeutics - Contacts, Employees, Board Members, …
Curamir Therapeutics is a developer of miRNA-based cancer therapeutics.See details»
Lan Bo Chen – Curamir Therapeutics, Inc.
Dr. Chen is Professor Emeritus of Pathology at Harvard Medical School. He is the author of over 200 academic publications and is the founder of several successful biotechnology companies …See details»
Delos Capital Announces the Launch of Curamir Therapeutics Inc.
HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering …See details»
Curamir Therapeutics Raises $10M in Series A Funding
Sep 23, 2019 Curamir Therapeutics, a Woburn, MA-based developer of miRNA-based cancer therapeutics, raised $10M in Series A funding. The round was led by Delos Capital.. Curamir …See details»
Curamir Therapeutics Launches with $10M Series A
Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, …See details»
Curamir Therapeutics-动脉网
Curamir Therapeutics致力于开发基于micro RNA（miRNA）的癌症疗法。该公司基于其专有的miRNA工程平台和对癌症生物学的洞察力，开发创新的疗法，旨在解决尚未满足的需求，以克 …See details»
Thomas Dahl – Curamir Therapeutics, Inc.
Dr. Dahl has more than 25 years of experience in product development including small molecules, biologics, cell therapy and devices. Dr. Dahl has held senior management positions in several …See details»
Cura Therapeutics - adMare Bio
Toronto Office. MaRS Centre, West Tower 661 University Ave., Suite 405 Toronto, Ontario, Canada M5G 1M1. T. 416.673.8100See details»
News – Curamir Therapeutics, Inc.
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering …See details»